The facility will manufacture filtration systems for biotechnology, pharmaceuticals and blood banking. Pall anticipates double-digit growth in sales for these products over the next three to five years. The Hauppauge plant will double Pall's production capacity.
Pall Corporation specializes in filtration, separation and purification for clients in the biotechnology, pharmaceutical, semiconductor, municipal drinking water, aerospace, blood banking and transfusion industries.
NOT FOR REPRINT
© Touchpoint Markets, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to asset-and-logo-licensing@alm.com. For more inforrmation visit Asset & Logo Licensing.
